Introduction: Healthy physiological systems exhibit fractal regulation (FR), generating similar fluctuation patterns in physiological outputs across different time scales. FR in motor activity is degraded in dementia, and the degradation correlates to cognitive decline. We tested whether degraded FR predicts Alzheimer's disease dementia.
Introduction
Outputs of many physiological systems display intrinsic self-similarity, or fractal patterns, across a wide range of temporal scales from seconds up to 24 hours, suggesting an underlying fractal regulatory mechanism [1, 2] . Fractal regulation (FR) challenges the traditional theory of homeostasis as it indicates that the physiological systems do not simply settle down to a stable state [1, [3] [4] [5] . Numerous studies have provided an overwhelming evidence that FR is a hallmark of healthy physiology, imparting considerable physiological advantage in terms of plasticity and adaptability (i.e., system integrity despite vastly changing conditions) [1, [3] [4] [5] . For instance, FR in cardiac function is degraded with aging and under varied pathological conditions [6] ; and such degradation is associated with decreased survival in patients with stroke or myocardial infarction [7] [8] [9] .
Our previous cross sectional study revealed that FR in motor activity is degraded with aging and in Alzheimer's disease (AD) [10] , and in a short longitudinal study, we found that the degradation of FR in motor activity over time is associated with cognitive decline in very old adults with dementia [11] . The goal of the present study is to determine whether FR perturbation at baseline in older individuals without dementia is associated with increased risk of the development of AD dementia and mild cognitive impairment (MCI) and rate of cognitive decline. To achieve this goal, we analyzed the data of 1097 older adults participating in the Memory and Aging Project (MAP) at Rush AD Center [12] . Subjects have been followed up for up to 11 years at the time of analysis. FR at baseline was evaluated using wrist actigraphy continuously monitored for up to 10 days. To evaluate the cognitive function and to identify AD dementia and MCI development, a battery of 21 neuropsychological tests and a detailed clinical evaluation were administered each year during the baseline and follow-up assessments. We hypothesized that subjects with more degraded FR at baseline were at increased risk for incident AD dementia and MCI and had a faster cognitive decline.
Methods

Subjects
The MAP is an on-going longitudinal, community-based cohort study of aging and dementia that began in 1997 [12] . Actigraphy was added in 2005. At the time of analysis (July 07, 2016), 1836 participants were enrolled in the MAP (parent study). Among them, 348 participants died; 79 withdrew before actigraphy was added; and 54 could not be followed (e.g., moving out of the state). Of the remaining 1355 who were eligible for actigraphy assessment, 16 refused to participate, and 30 had yet to have device placement. Thus, there were 1309 subjects who had actigraphy assessment(s). As compared with the parent study, these 1309 participants had similar baseline age (79.7 6 0.2 years old, parent study: 79.9 6 0.2, P . .1), but had slightly more female subjects (76.8%, parent study: 73.7%, P 5 .046) and higher baseline cognitive score (0.10 6 0.02, parent study: 0.00 6 0.02, P , .01). Further exclusion criteria in the present study were as follows: (1) baseline dementia (103); (2) bad quality baseline actigraphy (10; see Sub-Section 2.2); and (3) no valid baseline or at least one follow-up cognitive assessment to allow the determination of incident AD dementia and MCI and rate of cognitive decline (99). Thus, 1097 subjects (including 855 without MCI at baseline) were included in the final analysis. Written informed consent was obtained from all participants. The study was approved by the Institutional Review Boards of Rush University Medical Center and Partners Healthcare and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Data collection and preprocessing
For assessment of daily motor activity (Fig. 1) , subjects wore an activity monitor (Actical, Philips Respironics, Bend, OR) on their nondominant wrist for up to 10 days. The device predominantly measures acceleration in a direction parallel to the face of the device with a continuous sampling frequency of 32 Hz and integrates the data into a proprietary count value every 15 seconds. To ensure good signal quality, all actigraphic recordings were checked with the assistance of a self-designed MATLAB GUI program (Ver. R2015a, the MathWorks Inc., Natick, MA, USA). The most common types of quality issues were as follows: (1) isolated huge spikes with amplitude going beyond 10 standard deviations (SDs) away from the individual global mean levels; and (2) sequences of zeros with duration . 60 minutes during the daytime (likely occurred when subjects took the device off). The episodes with those issues were marked as gaps [13, 14] .
Clinical diagnoses and cognitive assessment
Cognitive function was assessed with a battery of 21 neuropsychological tests administered each year. Nineteen tests across a range of cognitive abilities were used to construct measures of five cognitive domains: (1) episodic memory (based on seven tests including Word List Recall, Word [15] . To obtain domain-specific measures, individual tests within each domain were first z-scored based on the corresponding baseline means and SDs of all subjects in the cohort and then averaged across the tests. In addition, a global composite cognitive measure was obtained by averaging the 19 z-scored cognitive tests. For these cognitive measures, 0 represents the mean and 1 approximates 1 SD of the baseline score of all MAP participants. Positive scores indicate better cognitive performance. Clinical diagnosis of AD dementia was based on the criteria of the joint working group of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association [16] . Diagnosis of MCI was rendered for persons who were judged to have cognitive impairment by the neuropsychologist but did not meet criteria for dementia by the clinician [17] .
Previously proposed risk factors for AD
Several physiological functions including physical activity, sleep, and daily rhythmicity of motor activity are reportedly associated with risk of AD dementia [18] [19] [20] [21] . Specially, both reduced total daily activity [20] and increased sleep fragmentation [22] are associated with increased risk for incident AD in measures derived from the same actigraphic data as we use in this study. To determine the separate effects of FR on incident AD dementia, incident MCI, and cognitive decline, we considered and accounted for the potential effects of the following: (1) total daily activity defined by the average sum of all daily activity counts recorded [23] ; (2) sleep fragmentation index developed by Lim et al. [24] that represents the probability of having an arousal (e.g., a non-zero activity count) after a long (w5 min) period of rest (i.e., sleep); and (3) interdaily stability that reflects the stability of circadian/daily activity rhythms [25] .
Assessment of FR
To assess FR, we performed the detrended fluctuation analysis of actigraphic data to examine the temporal correlations of activity fluctuations at multiple time scales, which results in a fluctuation amplitude F(n) that is a function of time scales n [13, 26] . A power-law form of F(n), that is, F(n)wn a , indicates a fractal structure in the fluctuations (Fig. 1C) [6, 14, 27, 28] , indicating the most complex underlying control mechanisms. We note that gaps identified in data recordings (see 2.2 Data collection and pre-processing) were skipped when performing the detrended fluctuation analysis to avoid any potential effects of interpolating missing data and/or manipulating the signal (e.g., stitching the rest data after removing the missing data) on F(n) [10] . Previous studies showed that cognitive impairment in patients with dementia is associated with smaller a at time scales , w90 minutes [11] . Thus, we quantified a at time scales between 1.25 and 90 minutes in this study (Fig. 1 ).
Statistical analysis
We performed three types of statistical analyses. (1) Coxproportional hazards models tested the association of FR metric a with incident AD dementia. The core model included baseline a as a predictor adjusted for demographics (i.e., age, sex, and education). To determine whether the observed association is driven by or independent of physical activity, we augmented the core model by including a term for total daily activity level (adjusted model 1). Similarly, to determine the potential effect of sleep quality, a term for sleep fragmentation index was included in the core model (adjusted model 2); and to determine the potential effect of daily activity rhythm, a term for interdaily stability was included (adjusted model 3). (2) Similar Cox-proportional hazards models (the core and three adjusted models) were used to examine the association between FR and incident MCI using a subset of 855 subjects who did not have cognitive impairment at baseline. (3) To test the association between FR metric a at baseline and the subsequent change in cognitive performance, a linear mixed-effect model was used with the longitudinal measure of global cognition as the dependent variable, and the time in years since baseline, baseline a, and the interaction between time and baseline a as the fixed effects. The model also included random effects for intercept and slope and was adjusted for age, sex, education, and their interactions with time. In addition, to explore whether the FR-cognition association, if exists, is domain specific, the same linear mixed-effect model was repeated for each of the five cognitive domains. These statistical analyses were performed using SAS/STAT software (version 9.4 of the SAS System for Linux, SAS Institute Inc., Cary, NC, USA) and MATLAB Statistics and Machine Learning Toolbox (version R2016 b, The MathWorks Inc., Natick, MA, USA).
Results
Demographic and clinical characteristics of participants at baseline
Demographic and clinical characteristics of participants at baseline are summarized in Table 1 . Fig. 1 shows examples of baseline activity recordings and the corresponding detrended fluctuation analysis results of two subjects at the same age (w80 years old). In all 1097 participants, the FR metric a followed a normal distribution with the value ranging from w0.6 to w1.15 (Fig. 2) . a values that were all .0.5 suggest positive correlations in the temporal fluctuations of motor activity in all participants. a showed a weak, negative association with age (Pearson r 5 20.062, P 5 .040), that is, activity fluctuations are more random at older ages. There was a modest positive correlation between a and years of education that was marginally significant (r 5 0.051, P 5 .092). No sex difference was found in a (P . .1). Total daily activity was positively correlated to a (r 5 0.414, P , .0001). No correlation between sleep fragmentation index, and a was observed (P . .3). A positive correlation between interdaily stability, and a was observed (r 5 0.186, P , .0001).
FR and incident AD dementia
Over a period of up to 11 follow-up years, 220 out of 1097 (20.0%) subjects developed AD dementia an average of 4.6 years (median: 4; SD: 2.8) after baseline. The mean age at AD diagnosis was 89.3 (SD: 6.3) years ( Q4 Table 3 ). Using the Cox model adjusted for age, sex, and education, we found a strong association between a and incident AD dementia, with a hazard ratio (HR) of 1.31 (95% confidence interval [CI]: 1.15-1.49, P , .0001) for 1-SD decrease in a (w0.06). To illustrate the association, the predicted cumulative hazards for incident AD dementia by different level of a are shown in Fig. 3A . An individual with an a level at the 10th percentile (i.e., a 5 0.85) has a 1.8-fold higher risk of developing AD dementia compared with an individual with an a level at the 90th percentile (i.e., a 5 0.98). The magnitude of the effect is equivalent to the effect of being w5.2 years older (HR for 1 year older 5 1.12; see Table 2 ). Indeed, the subject who had the lower FR metric a in Fig. 1C developed AD 1 year after baseline; and the subject who had the higher a in Fig. 1C did not develop AD over the follow-up of 6 years. The FR-AD association remained when we included only the 855 participants who had no MCI at baseline (i.e., for 1-SD decrease in a, HR 5 1.28, 95% CI 1.07-1.52, P 5 .0055).
The association between a and the risk of developing AD persisted after controlling for total daily activity, sleep fragmentation, or interdaily stability (Table 2 ). In the model that includes both total daily activity and a, decreased total daily activity is also associated with an increased AD risk (for 1-SD decrease in total daily activity, HR 5 1.24, 95% CI 1.03-1.49, P 5 .02), suggesting an independent effect of physical activity. In the model that includes both sleep fragmentation index and a, the effect of sleep fragmentation index on incident AD was not significant (P ..1). In the model that includes both interdaily stability and a, the effect of interdaily stability was not significant (P . .1).
FR and incident MCI
Among the 855 subjects without MCI at baseline, 344 (40.2%) subjects developed MCI during the follow-up. The mean time lag was 3.4 years (median: 2; SD: 2.7) after baseline. The mean age at MCI diagnosis was 86.3 (SD: 6.1) years. After adjusting for the effects of age, sex, and education, there was an association between a and the risk of developing MCI, with an HR of 1.15 (95% CI: 1.02-1.29, P 5 .018) per 1-SD decrease in a (w0.06). To illustrate the association, the predicted cumulative hazards for 378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435  436  437  438  439  440  441  442  443  444   445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476  477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496  497  498  499  500  501  502  503  504  505  506  507  508  509  510 incident MCI by different level of a are shown in Fig. 3B . An individual with the lower a level (10th percentile) is at a 1.3-fold higher risk of developing MCI compared with an individual with the higher a level (90th percentile). The magnitude of the effect is equivalent to the effect of being w3.0 years older.
The association between a and the risk of developing MCI persisted after controlling for sleep fragmentation or interdaily stability, that is, HR for 1-SD decrease in a was 1.16 after controlling for sleep fragmentation index (95% CI 1.03-1.30, P 5.013) and was 1.16 after controlling for interdaily stability (95% CI 1.03-1.31, P 5.015) ( Table 3) . When including both a and total daily activity in the model, the significance level for the association between a and the MCI risk was on borderline (P 5 .083) while the association between total daily activity and the MCI risk was not significant (P . .3).
FR and cognitive decline
Global cognition declined over time with the average annual decrease of 0.080 6 0.004 (SE Q5 ) (P , .0001, Table 4 ). In a linear mixed-effect model adjusted for age, sex, and education, cognitive decline was much faster for subjects with smaller a, that is, for 1-SD decrease in a, the annual decrease in global cognition was accelerated by 0.010 6 0.004 (P 5 .009), which represents 12.5% of the average annual decline rate and is equivalent to an accelerated decline for being 2 years older (Table 4) . To illustrate the association between baseline a values and rate of global cognitive decline, the predicted trajectories of global cognitive score for different levels of a are shown in Fig. 4 . The association persisted after controlling for total daily activity (for 1-SD decrease in a, estimate 5 0.010 6 0.004, P 5 .015), sleep fragmentation index (for 1-SD decrease in a, estimate 5 0.093 6 0.004, P 5 .016), or interdaily stability (for 1-SD decrease in a, estimate 5 0.094 6 0.004, P 5 .018) ( Table 4) .
Using similar mixed models, we also examined the associations of baseline a with the rate of decline in the five cognitive domains, separately (Tables 5-9). We found that a was consistently associated with episodic memory (for 1-SD decrease in a, estimate 5 0.011 6 0.005, P 5 .014), working memory (for 1-SD decrease in a, estimate 5 0.0083 6 0.004, P 5 .022), and perceptual speed (for 1-SD decrease in a, estimate 5 0.012 6 0.003, Results for per 1-SD decrease.
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Discussion
By following a large cohort of older persons for up to 11 years, we found that subjects with more degraded FR in motor activity (i.e., weaker temporal activity correlations at time scales , 1.5 hours as characterized by lower a values) had a higher risk for the subsequent development of AD dementia and MCI. Consistently, lower a was also associated with a faster decline of global cognitive function over time. Those associations did not change across demographic lines (such as age, sex, and education) and were independent from other risk factors including physical activity, sleep, and daily activity rhythm.
The concept of FR has been applied in many fields of physiology to evaluate the health status of physiological systems and to predict the clinical outcomes in patients with diseases such as stroke and myocardial infarction [1, 7, 29] . This is the first large, community-based study to our knowledge, however, demonstrating the potential of this novel concept for predicting the risk for AD and MCI. In the cohort of the present study, the average time lag between baseline assessments and clinical AD diagnosis is 4.6 years, suggesting that the perturbation of FR is already detectable 4.6 years before the clinical AD onset. Moreover, our results also show that the ability of FR to predict incident AD dementia and MCI risk is independent of many other AD risk factors including age, physical activity, sleep fragmentation, and stability of daily activity rhythms. After adjusting for the effects of a, none of these traditional measures was significantly associated with AD risk or MCI risk, except that (1) age was still associated with incident AD dementia and incident MCI, and (2) physical activity level was still associated with incident AD dementia. Our results indicate that FR may be another risk factor for AD, and its degradation may be integral to AD pathology.
Previous studies showed that AD and other brain pathologies affect diverse clinical phenotypes and are related to level of diverse motor constructs [30] [31] [32] [33] [34] and that poorer motor function (e.g., lower physical activity level, loss of muscle strength and bulk, and physical frailty) predicts MCI, AD, and cognitive decline [20, 34] . These findings raise the hypothesis that motor dysfunction and cognitive impairment may share certain common pathophysiology (i.e., brain pathology). Supporting this hypothesis, the present study showed a strong association between degraded FR of motor activity and cognitive decline. Regarding the specific neuronal circuitries linking motor regulation and cognition, the neural network of the circadian control system may be one of the candidates because disrupting the circadian control acutely causes cognitive impairment [35, 36] , and long-term circadian disruption, as occurred to chronic shift work, is associated with accelerated brain aging [37] . Indeed, it is proposed that circadian dysfunction is one early sign of AD, preceding the onset of cognitive symptoms [38] and that it may exacerbate the progression of this disease [18, 19, 21, 39] . More relevant to FR, our animal and human studies showed the circadian control system impacts fractal activity regulation [2] . In rats, lesioning of the suprachiasmatic nucleus-the well-established central circadian clock in mammals [40] -causes a breakdown of fractal activity patterns with different temporal structures at time scales , 2 hours and .4 hours [41] . In a human postmortem study, perturbed FR was associated with reductions in the amounts of two major circadian neurotransmitters in the suprachiasmatic Table 6 The fractal regulation metric a and decline of working memory nucleus (i.e., the vasopressinergic and neurotensinergic neurons) [42] . In addition, fractal activity patterns are perturbed in chronic shift workers during night shifts [43] ; and certain interventions such as light treatments that are normally used to treat sleep and circadian disorders turn out to be beneficial for cognition and fractal activity regulation in patients with dementia [11] . Thus, circadian dysfunction may explain degraded fractal activity regulation and its prediction for AD risk.
On the other hand, it is important to note that FR is different from the regulation of daily/circadian rhythms [44] . Based on models of physical systems [45, 46] , it has been hypothesized that fractal physiological fluctuations reflect a network of elaborate regulatory processes interacting across multiple system components over a range of temporal and spatial scales [1] . Our animal study showed that the suprachiasmatic nucleus itself cannot generate fractal patterns [47] , supporting the network theory of FR. Moreover, we found in this study that fractal activity regulation predicts AD and MCI, independent of the two accepted circadian/ sleep measures (i.e., sleep fragmentation and daily activity stability). Therefore, future studies are required to determine the neural circuitry for FR and the neuroanatomical/neuropathological changes underlying the altered FR observed in those individuals at risk for AD.
Despite the lack of fully mechanistic understanding of FR, a few recent studies have explored possible interventions that can improve or maintain FR. For instance, an animal study showed that maintaining a high physical activity level can help counteract the adverse effect of aging on FR [48] . In older adults in the middle-to-late stages of dementia, increased daily light exposure may diminish or even abolish the aging-induced degradation of FR [11] . Whether improving FR symptomatically using exercise and/or light interventions can help prevent or delay the onset of cognitive impairment merits further investigations.
Population aging is widespread across the world. How to monitor health status of the elderly reliably and cost efficiently is a contemporary challenge. Related to AD, one of the important tasks is to identify individuals at a higher risk for AD at an earlier stage when interventions may be more effective [49] [50] [51] [52] . The rapid advances in the technology of wearable devices for assessment of daily activities provide new opportunities to address the challenge. In recent years, actigraphy has become frequently used to examine physical activity in clinical and research studies because the unobtrusive monitoring requires less cooperation from participants, allowing their usual daily behaviors [21, 22, 53] . In this study, we further demonstrated the value of an actigraphic measure based on nonlinear dynamic theory-FR-for predicting MCI and AD risk.
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